ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 071

Patient Reported Outcomes and Resilience in Pediatric Systemic Lupus Erythematosus

Lauren Ambler1, Rula Issa 2, Stephanie Pan 2 and Rebecca Trachtman 2, 1Mount Sinai Hospital, New York, 2Icahn School of Medicine at Mount Sinai, New York

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Disease Activity, Lupus, Pediatric rheumatology, quality of life, resiliency

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: It has been established that pediatric Systemic Lupus Erythematous (pSLE) is associated with lower health-related quality of life (HRQOL); however, there are few studies that evaluate specific HRQOL constructs in pSLE. We designed this cross-sectional study to evaluate 1) Patient Reported Outcomes, measured by a) the Patient Reported Outcomes Measurement Information System (PROMIS) short forms, and b) PROMIS computerized adaptive tests (CATs); and 2) Resilience, measured by the 10-item Connor-Davidson Resilience Scale (CD-RISC 10) in children with pSLE. We hypothesize that PROMIS CATs will be a reliable HRQOL tool for use in pSLE and that the scores will correlate with patient resilience measures.

Methods: A convenience sample of patients with pSLE (N = 9) was recruited from a single academic center. Patients aged 11 to 18 years completed 7 of the available pediatric PROMIS Short Forms and CATs (Anxiety, Depressive symptoms, Fatigue, Mobility, Pain Interference, Peer Relationships, Physical Activity) as well as the Patient Global Health Assessment and the CD-RISC 10 questionnaire for resilience. Additionally, the treating physician completed the Physician Global Disease Activity Scale and the Systemic Lupus Erythematous Disease Activity Index (SLEDAI) for each patient. Descriptive summaries were reported, and the correlations of the various measures were evaluated using Spearman correlation coefficients.

Results: All 9 patients approached completed the PROMIS CATs, Patient Global Health Assessment, and CD-RISC 10. Median age was 14 years (IQR 13 – 16 years), and mean SLEDAI score was 5.1 (SD 4.3). Patient Global Health Assessment mean score was 6.8 (SD 2.7), Physician Global Health Assessment mean score was 1.8 (SD 1.1), and CD-RISC 10 mean score was 24.2 (SD 9.7). All PROMIS domains showed strong positive correlation between the Short Form and CAT reaching statistical significance in all except Anxiety (p=0.07). Increased anxiety PROMIS scores had a strong negative correlation with the Patient Global Health Assessment. Higher CD-RISC 10 scores (indicating higher resilience) demonstrated positive correlation with increased SLEDAI scores. There was no significant correlation between the Physician Global Disease Activity Scale and any PROMIS domain or the CD-RISC 10.

Conclusion: Our results demonstrate that the PROMIS CATs are feasible to administer in an outpatient pediatric rheumatology setting and that they are a reliable tool when compared to the PROMIS Short Forms. Anxiety was strongly negatively correlated with the Patient Global Health Assessment score, suggesting that anxiety may uniquely impact overall perception of health in patients with pSLE. Although there was no significant correlation between the CD-RISC 10 and either the PROMIS or the Patient Global Health Assessment, CD-RISC 10 scores in our population were substantially lower than those of adolescents with other chronic medical conditions. Our major limitation was small sample size, and larger comparative studies are needed to evaluate resilience scores in pSLE patients, as well as their correlations with disease activity and HRQOL.


Disclosure: L. Ambler, None; R. Issa, None; S. Pan, None; R. Trachtman, None.

To cite this abstract in AMA style:

Ambler L, Issa R, Pan S, Trachtman R. Patient Reported Outcomes and Resilience in Pediatric Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/patient-reported-outcomes-and-resilience-in-pediatric-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcomes-and-resilience-in-pediatric-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology